1.
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
by Wijnans, Leonoor
Vaccine, 2012, Vol.31 (8), p.1246-1254
2.
Severity of symptoms persists for decades in fibromyalgia—a 26-year follow-up study
by Isomeri, Risto
Clinical rheumatology, 2018-01-09, Vol.37 (5), p.1383-1388
3.
Parkinson’s disease and insomnia
by Ylikoski, Ari
Neurological sciences, 2015-06-23, Vol.36 (11), p.2003-2010
4.
HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
by Ollila, Hanna M
American journal of human genetics, 2015-01-08, Vol.96 (1), p.136-146
5.
Parkinson's Disease and Restless Legs Syndrome
by Ylikoski, Ari
European neurology, 2015-04, Vol.73 (3-4), p.212-219
6.
Shift-work and cardiovascular disease: a population-based 22-year follow-up study
by Hublin, Christer
European journal of epidemiology, 2010-01-01, Vol.25 (5), p.315-323
7.
Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation
by Poli, Francesca
Vaccine, 2012, Vol.31 (6), p.994-1007
8.
Prevalence of sleep apnea syndrome in lone atrial fibrillation: A case-control study
by PORTHAN, Kimmo Markus
Chest, 2004, Vol.125 (3), p.879-885
9.
Familial Aggregates in Obstructive Sleep Apnea Syndrome
by Guilleminault, Christian
Chest, 1995-06, Vol.107 (6), p.1545-1551
10.
Nasal-CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome : A randomized study
by LOJANDER, J
Chest, 1996, Vol.110 (1), p.114-119
11.
Sleeptalking in twins: epidemiology and psychiatric comorbidity
by Hublin, C
Behavior genetics, 1998-07, Vol.28 (4), p.289-298
12.
Solriamfetol for the Treatment of Excessive Sleepiness in OSA
by Strollo, Patrick
Chest, 2018-11-21, Vol.155 (2), p.364-374
13.
Sleep disorder related to Parkinson's disease
by Partinen, M
Journal of neurology, 1997-04, Vol.244 (4 Suppl 1), p.S3-S6
14.
Prevalence of Sleep Apnea Syndrome in Lone Atrial Fibrillation
by Porthan, Kimmo Markus
Chest, 2004-03, Vol.125 (3), p.879-885
15.
HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
by Ollila, Hanna M
American journal of human genetics, 2015-05-07, Vol.96 (5), p.852-852
16.
Daytime Sleepiness and Vascular Morbidity at Seven-Year Follow-up in Obstructive Sleep Apnea Patients
by Partinen, Markku
Chest, 1990-01, Vol.97 (1), p.27-32
17.
Nasal-CPAP, Surgery, and Conservative Management for Treatment of Obstructive Sleep Apnea Syndrome
by Lojander, Jukka
Chest, 1996-07, Vol.110 (1), p.114-119
18.
SNORING AND CEREBRAL INFARCTION
by Partinen, Markku
The Lancet (British edition), 1985, Vol.326 (8468), p.1325-1326
19.
PRAZOSIN CONTRAINDICATED IN PATIENTS WITH NARCOLEPSY
by Guilleminault, Christian
The Lancet (British edition), 1988-08-27, Vol.332 (8609), p.511-511
20.
SNORING AS A RISK FACTOR FOR HYPERTENSION AND ANGINA PECTORIS
by Koskenvuo, Markku
The Lancet (British edition), 1985, Vol.325 (8434), p.893-896
